A three-way crossover clinical pharmacological study to evaluate a drug interaction on P-gp at blood brain barrier between histamine H1 receptor antagonist ebastine and P-gp inhibitor verapamil by using saccadic eye movement analyzing system and visual analogue scale (VAS) in healthy Japanese male volunteers

Trial Profile

A three-way crossover clinical pharmacological study to evaluate a drug interaction on P-gp at blood brain barrier between histamine H1 receptor antagonist ebastine and P-gp inhibitor verapamil by using saccadic eye movement analyzing system and visual analogue scale (VAS) in healthy Japanese male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Apr 2007

At a glance

  • Drugs Ebastine (Primary) ; Verapamil
  • Indications Allergic rhinitis; Angina pectoris; Arrhythmias; Hypertension; Urticaria
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Apr 2007 Status changed from suspended to completed.
    • 07 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top